BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 29544641)

  • 1. Human Thymidylate Synthase Inhibitors Halting Ovarian Cancer Growth.
    Ferrari S; Severi L; Pozzi C; Quotadamo A; Ponterini G; Losi L; Marverti G; Costi MP
    Vitam Horm; 2018; 107():473-513. PubMed ID: 29544641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic Peptides Acting as Allosteric Inhibitors of Human Thymidylate Synthase and Cancer Cell Growth.
    Pacifico S; Santucci M; Luciani R; Saxena P; Linciano P; Ponterini G; Lauriola A; D'Arca D; Marverti G; Guerrini R; Costi MP
    Molecules; 2019 Sep; 24(19):. PubMed ID: 31561530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance.
    Taddia L; D'Arca D; Ferrari S; Marraccini C; Severi L; Ponterini G; Assaraf YG; Marverti G; Costi MP
    Drug Resist Updat; 2015 Nov; 23():20-54. PubMed ID: 26690339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Peptidic Thymidylate-Synthase Inhibitor Loaded on Pegylated Liposomes Enhances the Antitumour Effect of Chemotherapy Drugs in Human Ovarian Cancer Cells.
    Marverti G; Gozzi G; Maretti E; Lauriola A; Severi L; Sacchetti F; Losi L; Pacifico S; Ferrari S; Ponterini G; Leo E; Costi MP; D'Arca D
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32585842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein-protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthase.
    Cardinale D; Guaitoli G; Tondi D; Luciani R; Henrich S; Salo-Ahen OM; Ferrari S; Marverti G; Guerrieri D; Ligabue A; Frassineti C; Pozzi C; Mangani S; Fessas D; Guerrini R; Ponterini G; Wade RC; Costi MP
    Proc Natl Acad Sci U S A; 2011 Aug; 108(34):E542-9. PubMed ID: 21795601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural analyses of human thymidylate synthase reveal a site that may control conformational switching between active and inactive states.
    Chen D; Jansson A; Sim D; Larsson A; Nordlund P
    J Biol Chem; 2017 Aug; 292(32):13449-13458. PubMed ID: 28634233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proprotein convertase inhibition: Paralyzing the cell's master switches.
    Klein-Szanto AJ; Bassi DE
    Biochem Pharmacol; 2017 Sep; 140():8-15. PubMed ID: 28456517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tomudex (ZD1694): from concept to care, a programme in rational drug discovery.
    Jackman AL; Boyle FT; Harrap KR
    Invest New Drugs; 1996; 14(3):305-16. PubMed ID: 8958186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and Functional Characterization of the Human Thymidylate Synthase (hTS) Interface Variant R175C, New Perspectives for the Development of hTS Inhibitors.
    Pozzi C; Ferrari S; Luciani R; Costi MP; Mangani S
    Molecules; 2019 Apr; 24(7):. PubMed ID: 30959951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymidylate synthase inhibition: a structure-based rationale for drug design.
    Costi MP
    Med Res Rev; 1998 Jan; 18(1):21-42. PubMed ID: 9436180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standing the test of time: targeting thymidylate biosynthesis in cancer therapy.
    Wilson PM; Danenberg PV; Johnston PG; Lenz HJ; Ladner RD
    Nat Rev Clin Oncol; 2014 May; 11(5):282-98. PubMed ID: 24732946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymidylate synthase: a critical target for cancer chemotherapy.
    Rose MG; Farrell MP; Schmitz JC
    Clin Colorectal Cancer; 2002 Feb; 1(4):220-9. PubMed ID: 12450420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass spectrometric/bioinformatic identification of a protein subset that characterizes the cellular activity of anticancer peptides.
    Genovese F; Gualandi A; Taddia L; Marverti G; Pirondi S; Marraccini C; Perco P; Pelà M; Guerrini R; Amoroso MR; Esposito F; Martello A; Ponterini G; D'Arca D; Costi MP
    J Proteome Res; 2014 Nov; 13(11):5250-61. PubMed ID: 25196676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticancer activity of the intraperitoneal-delivered DFP-10825, the cationic liposome-conjugated RNAi molecule targeting thymidylate synthase, on peritoneal disseminated ovarian cancer xenograft model.
    Iizuka K; Jin C; Eshima K; Hong MH; Eshima K; Fukushima M
    Drug Des Devel Ther; 2018; 12():673-683. PubMed ID: 29636601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human dihydrofolate reductase and thymidylate synthase form a complex in vitro and co-localize in normal and cancer cells.
    Antosiewicz A; Jarmuła A; Przybylska D; Mosieniak G; Szczepanowska J; Kowalkowska A; Rode W; Cieśla J
    J Biomol Struct Dyn; 2017 May; 35(7):1474-1490. PubMed ID: 27187663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines.
    van Triest B; Pinedo HM; van Hensbergen Y; Smid K; Telleman F; Schoenmakers PS; van der Wilt CL; van Laar JA; Noordhuis P; Jansen G; Peters GJ
    Clin Cancer Res; 1999 Mar; 5(3):643-54. PubMed ID: 10100718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic Acid-Peptide Conjugates Combine Selective Cancer Cell Internalization with Thymidylate Synthase Dimer Interface Targeting.
    Marverti G; Marraccini C; Martello A; D'Arca D; Pacifico S; Guerrini R; Spyrakis F; Gozzi G; Lauriola A; Santucci M; Cannazza G; Tagliazucchi L; Cazzato AS; Losi L; Ferrari S; Ponterini G; Costi MP
    J Med Chem; 2021 Mar; 64(6):3204-3221. PubMed ID: 33710891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymidylate synthase structure, function and implication in drug discovery.
    Costi MP; Ferrari S; Venturelli A; Calò S; Tondi D; Barlocco D
    Curr Med Chem; 2005; 12(19):2241-58. PubMed ID: 16178783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ligand binding and conformational switching on intracellular stability of human thymidylate synthase.
    Berger SH; Berger FG; Lebioda L
    Biochim Biophys Acta; 2004 Jan; 1696(1):15-22. PubMed ID: 14726200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomolecular study of human thymidylate synthase conformer-selective inhibitors: New chemotherapeutic approach.
    El-Mesallamy HO; El Magdoub HM; Chapman JM; Hamdy NM; Schaalan MF; Hammad LN; Berger SH
    PLoS One; 2018; 13(3):e0193810. PubMed ID: 29538414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.